Jørgensen, C. L., Ejlertsen, B., Bjerre, K. D., Balslev, E., Nielsen, D. L., & Nielsen, K. V. (2013). Gene aberrations of RRM1 and RRM2B and outcome of advanced breast cancer after treatment with docetaxel with or without gemcitabine. BioMed Central.

Jørgensen, Charlotte LT, Bent Ejlertsen, Karsten D. Bjerre, Eva Balslev, Dorte L. Nielsen, και Kirsten V. Nielsen. Gene Aberrations of RRM1 and RRM2B and Outcome of Advanced Breast Cancer After Treatment With Docetaxel With or Without Gemcitabine. BioMed Central, 2013.

Jørgensen, Charlotte LT, et al. Gene Aberrations of RRM1 and RRM2B and Outcome of Advanced Breast Cancer After Treatment With Docetaxel With or Without Gemcitabine. BioMed Central, 2013.